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PROTECTING EGG DONORS AND HUMAN EMBRYOS—
THE FAILURE OF THE SOUTH KOREAN BIOETHICS
AND BIOSAFETY ACT
Mukta Jhalani†
Abstract: Human embryonic stem cells have the potential to treat many physical
and neurological disorders due to their unique ability to transform into any type of human
cell. The process of deriving stem cells from human embryos, however, raises important
ethical and regulatory issues. Embryonic stem cell research requires a steady source of
human eggs to create embryos that are destroyed during stem cell extraction.
International declarations and guidelines protect the two most vulnerable participants of
embryonic stem cell research: women who donate eggs for research purposes and human
embryos that are destroyed in the research.
In 2005, South Korea passed the Bioethics and Biosafety Act to regulate
biotechnology research. In its current form, the Bioethics and Biosafety Act fails to
adequately protect egg donors and human embryos. The Bioethics and Biosafety Act
does not have adequate safeguards to protect egg donors, such as a requirement of
voluntary consent and a requirement that egg donors understand the research and its
potential risks. The Institutional Review Boards established by the Bioethics and
Biosafety Act are not sufficiently removed from the research institution to guarantee that
egg donors are not exploited. Additionally, this legislation fails to appropriately regulate
the use of human embryos in scientific research as required by international guidelines.
The Bioethics and Biosafety Act should include more detailed provisions dealing with the
adequacy and quality of informed consent that is obtained from egg donors.
Furthermore, Korea should amend its law to limit the use of human embryos in stem cell
research so that the embryos are not unnecessarily destroyed.

I.

INTRODUCTION

To realize its goal of becoming the “world-best science nation,” the
Republic of Korea (“Korea”) is investing tremendous money and resources
into scientific research and development.1 Embryonic stem cell research is
one specific area of study that the Korean government has encouraged and
supported. In May 2006, the Korean government decided to invest 430
billion won,2 or $454 million, into stem cell research over the next decade.3

†
Juris Doctor expected in 2009, University of Washington School of Law. The author would like
to thank Professor Sean O’Connor and the editorial staff at the Pacific Rim Law and Policy Journal for
their guidance and assistance throughout the writing process. The author would also like to thank her
family and close friends for their support and patience.
1
Korea Gears Up Efforts to Become Science Leader, KOREA.NET, Dec. 20, 2007,
http://www.korea.net (search for “Korea gears up efforts to become science leader”) (last visited Apr. 26,
2008).
2
Won is the official currency of South Korea. Central Intelligence Agency: The World Factbook,
South Korea, https://www.cia.gov/library/publications/the-world-factbook/geos/ks.html (last visited Apr.
26, 2008).
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The money was allocated to support research on adult and embryonic stem
cells as well as to strengthen the ethical infrastructure underlying stem cell
research.4 Korea’s strong support for stem cell research has required it to
pass new legislation to guide this innovative, yet controversial, field. In
2003, Korea passed the Bioethics and Biosafety Act (“Bioethics Act”) to
deal with advances in biotechnology, particularly in stem cell research.5 The
Bioethics Act came into effect at the beginning of 2005.6
No binding international standards currently govern embryonic stem
cell research. In 1998, the United Nations (“UN”) passed a resolution
banning all forms of human cloning that are “incompatible with human
dignity and the protection of human life.”7 However, it is a non-binding
declaration that was voted against by thirty-four member countries.8 Korea
voted against the UN resolution and the Korean representative to the UN
General Assembly made it clear that the resolution will not affect Korea’s
policy of allowing therapeutic cloning.9 As a result, the Korean Bioethics
Act allows therapeutic cloning, yet places a ban on reproductive cloning.10
Reproductive cloning creates an embryo with the aim of producing a new,
genetically identical individual, whereas therapeutic cloning produces
embryos to be used in research.11 Thus, unlike reproductive cloning,
therapeutic cloning has the potential to help patients by replacing or
supplementing their damaged cells, tissues, or organs.12
Korea’s continued support of therapeutic cloning and embryonic stem
cell research arguably requires changes in the Bioethics Act to adequately
protect egg donors and human embryos from exploitation and to bring the
Act into compliance with international standards. Part II of this Comment
provides a brief introduction to the Bioethics Act and addresses the highly
3
Government to Spend $450 Million on Stem Cell Research, KOREA.NET, May 30, 2006,
http://www.korea.net (search for “Government to spend 450 million on stem cell research”) (last visited
Apr. 26, 2008).
4
Id.
5
UN JONG PAK, BIOETHICS, RESEARCH ETHICS, AND REGULATION 203 (Seoul National University
Press 2005).
6
Bioethics and Biosafety Act, Law No. 7150 of 2005 (an unofficial English translation), available
at www.ruhr-uni-bochum.de/kbe/Bioethics&BiosafetyAct-SouthKorea-v1.0.pdf [hereinafter Bioethics
Act].
7
Declaration on Human Cloning, G.A. Res. 59/280, U.N. Doc. A/RES/59/280 (Mar. 23, 2005).
8
U.N. GAOR, 59th Sess., 82nd plen. mtg. at 5, U.N. Doc. A/59/PV.82 (Mar. 8, 2005).
9
Id. See Korea: Korea to Continue Cloning Research, TODAY’S STEM CELL RESEARCH, Feb. 21,
2005, http://www.stemnews.com/archives/000362.html (last visited Apr. 26, 2008).
10
See Bioethics Act, supra note 6, art. 11.
11
Human Genome Project Information, Cloning Fact Sheet, http://www.ornl.gov/sci/techresources/
Human_Genome/elsi/cloning.shtml (last visited Apr.26. 2008).
12
Alan Colman & Alexander Kind, Therapeutic Cloning: Concepts and Practicalities, 18 TRENDS IN
BIOTECHNOLOGY 192, 192 (2000).
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publicized stem cell research scandal that took place in Korea after the
Bioethics Act became law. Part III argues that the Bioethics Act falls short
of international guidelines, such as the Declaration of Helsinki and the
Nuremberg Code, because it does not require voluntary informed consent or
comprehension of the research by egg donors. Additionally, the institutional
review boards (“IRB”) lack the independence necessary to monitor the
quality of informed consent obtained. Part IV raises questions about a
human embryo’s status as a potential human being and argues that Korea’s
legislation fails to protect human embryos by not limiting their use in
embryonic stem cell research. Part V recommends several approaches to
strengthen the protections for human research subjects and place limitations
on the use of human embryos in stem cell research. This Comment
ultimately concludes that Korea should make the necessary changes to the
Bioethics Act to stay consistent with international standards and ensure that
scientists are conducting ethical and legal research.
II.

JUST TWO YEARS AFTER THE BIOETHICS ACT CAME INTO EFFECT,
KOREA RECOGNIZED THE NEED TO AMEND IT

After several unsuccessful attempts, Korea finally passed the
Bioethics Act on December 29, 2003; it became effective on January 1,
2005.13 The Bioethics Act aims to promote biotech research that can be
“used to prevent or cure human diseases.”14 The Bioethics Act allows
scientists to conduct research on human embryos, but prohibits the
production of embryos for purposes other than pregnancy.15 The uncovering
of Korea’s infamous stem cell research scandal attracted the world’s
attention to the regulation of embryonic stem cell research in Korea. The
scandal prompted the Korean government to examine the effectiveness of
the Bioethics Act in preventing future ethical breaches by scientists and
protecting research subjects who participate in embryonic stem cell
research.16

13

PAK, supra note 5, at 203.
Bioethics Act, supra note 6, art. 1.
15
Bioethics Act, supra note 6, art. 13.
16
See Kim Tae-gyu, Korea Mulls Allowing Research Using Cloned Embryos, KOREA TIMES, Jan.
20, 2007.
14
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The Legislative History of the Bioethics Act Sheds Light on the
Struggles in Drafting a Bioethics Act that Promotes Scientific
Research and Protects Human Dignity

Between 1997 and 2003, Korea attempted to legislate a bioethics law
twelve times.17 In 2000, Korea’s Ministry of Science and Technology
(“MOST”) formed the Korean Bioethics Advisory Commission (“KBAC”)
to draft the first version of a bioethics law.18 KBAC completed and
submitted the framework for the Basic Law on Bioethics to MOST.19
KBAC recommended prohibiting both reproductive and therapeutic
cloning.20 This commission also suggested temporarily allowing stem cell
research on surplus frozen embryos from in vitro fertilization (“IVF”).21
MOST was not satisfied with these recommendations and did not submit its
version of the bioethics law to the Korean National Assembly.22
Instead, in May 2002, MOST proposed the Bill on the Prohibition of
Human Cloning and Stem Cell Research.23 Another government ministry,
the Ministry of Health and Welfare (“MHW”), also took up the issue of
drafting the bioethics bill.24 In contrast to MOST’s bill, which sought to
foster research and development of biotechnologies, MHW’s bill focused on
the issues of human dignity and safety.25 To consolidate the bills proposed
by the two governmental ministries, MHW formulated the Act on Bioethics
and Safety in July 2002.26 An associated gathering of citizen groups made
changes to MHW’s Act on Bioethics and Safety and drafted its own bill
entitled “Bioethics and Biosafety Act,” which amended the MHW bill.27
The changes made by the citizen groups included complete prohibition of
embryonic cloning and interspecies hybridization, as well as elevation of the
National Bioethics Committee’s status and function.28 The government
17

Sung-Goo Han, Young Je Yoo & Wha-Joon Rho, New Cloning Technologies and Bioethics
Issues: The Legislative Process in Korea, 13 EUBIOS J. ASIAN & INT’L BIOETHICS 205, 216 (2003).
18
Sang-yong Song, The Rise and Fall of Embryonic Stem Cell Research in Korea, ASIAN
BIOTECHNOLOGY & DEV. REV., Nov. 2006, at 65, 66.
19
Id.
20
Id.
21
Id. For a discussion of in vitro fertilization, see COLUMBIA ENCYCLOPEDIA (6th ed. 2007),
available at http://www.encyclopedia.com/doc/1E1-invitro.html.
22
Song, supra note 18, at 66.
23
PAK, supra note 5, at 192.
24
Id.
25
Kim Mikyung, An Overview of the Regulation and Patentability of Human Cloning and
Embryonic Stem Cell Research in the United States and Anti-Cloning Legislation in South Korea, 21
SANTA CLARA COMPUTER & HIGH TECH. L. J. 645, 684 (2005).
26
Id. at 684-85.
27
Id. at 685-86.
28
Id.
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reviewed the bills and finally produced a single bill to be considered by the
National Assembly.29 After a year-long discussion, on October 14, 2003, the
government bill, “Bioethics and Biosafety Act,” was referred to the Korean
National Assembly, the assembly that ultimately passed the Bioethics Act in
December 2003.30
B.

The Bioethics Act Establishes an Ethics Committee and Creates the
Requirement of IRBs to Oversee Embryonic Stem Cell Research

Although some of its provisions became applicable in 2003, the
Bioethics Act did not take effect until January 1, 2005.31 In March 2004,
MHW established the Bioethics and Biosafety Task Force Team (“Task
Force Team”), which was entrusted with the responsibility to “provide an
institutional framework on stem-cell research in order to ensure its
transparency and ethical integrity.”32 The Task Force Team was also
responsible for establishing and running the National Bioethics Committee
(“NBC”),33 the reviewing body responsible under the Bioethics Act for
overseeing bioethics and safety in the life sciences and biotechnologies.34
The Bioethics Act stipulates a ten-member NBC, made up of
scientists, ethicists, and government officials, to monitor any requested
research on human embryos for a period of ninety days after receiving the
request.35 Other important provisions of the Act include the following:
creation of IRBs,36 a total ban on human cloning,37 a ban on embryonic
cloning using somatic cell nuclear transfer (“SCNT”) except where the
Committee permits such research,38 and conditions and criteria for utilizing
embryos in scientific research.39

29

Id. at 686.
Id.
31
See Bioethics Act, supra note 6.
32
Press Release, Ministry of Health and Welfare, Bioethics and Safety Task Force Team Has Been
Launched (Mar. 4, 2004), http://english.mohw.go.kr/ (search for “Bioethics and Safety Task Force Team”)
(last visited Apr. 26, 2008).
33
Id.
34
Bioethics Act, supra note 6, art. 6.
35
Korea Okays Stem Cell Research, KOREA TIMES, Aug. 1, 2005.
36
Bioethics Act, supra note 6, art. 9.
37
Id. art. 11.
38
Id. art. 22.
39
Id. arts. 11-21.
30
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C.

The Hwang Embryonic Stem Cell Research Scandal and the
Circumstances Surrounding It Attracted International Attention

Under the newly enacted Bioethics Act, MHW approved the stem cell
research that Professor Hwang Woo-Suk had started at the Seoul National
University before the Bioethics Act came into effect.40 Less than four
months after the Bioethics Act came into effect, Professor Hwang announced
that he had made a breakthrough invention in stem cell research. In May
2005, Professor Hwang announced that his lab had been able to create
eleven human embryonic stem cell lines that were patient-specific.41 This
was the second major invention in less than one year made in Professor
Hwang’s lab.42 Just one year prior, in 2004, Professor Hwang had
announced that his team was able to create a stem cell line from a cloned
human embryo.43 The Korean government had reacted to this news by
issuing a stamp commemorating Professor Hwang’s achievements44 and
investing millions of dollars in his research lab.45
Some commentators have argued that under the strict requirements of
the Bioethics Act, only Professor Hwang was eligible to conduct stem cell
research at the time the Bioethics Act came into effect;46 the Additional
Provisions of the Act allowed someone who was engaged in embryonic stem
cell research prior to January 2005 to continue his research only if he had
worked in the field for more than three years or had published a paper in an
international journal.47 This provision allowed Professor Hwang, who had
published his 2004 scientific results in Science,48 to continue his work on
embryonic stem cell research uninterrupted, even after the Bioethics Act
came into effect. Although MHW allowed Professor Hwang to continue his

40

Korea Okays Stem Cell Research, supra note 35.
Erika Check, Korea’s Accelerating Stem-cell Work Prompts Calls for Global Ethical Rules, 435
NATURE 393 (2005). Patient-specific stem cells are created by taking genetic material from the patient
such that the resulting cells are a perfect match for the patient and there are no problems of rejection. Stem
Cells Tailored to Patients, BBC NEWS, May 20, 2005, http://news.bbc.co.uk/2/hi/health/4555023.stm (last
visited Mar. 16, 2008).
42
Chris Mason, The Korean Stem Cell Fiasco: Shifting the Focus, MEDICAL DEVICE TECHNOLOGY,
Mar. 2006, at 24, 24, available at http://www.devicelink.com/mdt/archive/06/03/002.html.
43
Id.
44
S. Korea Takes Lead in Stem Cell Research, NEWSDAY.COM, May 20, 2005,
http://www.newsday.com/news/health/ny-hsclon0521,0,2813316.story (last visited Apr. 17, 2008).
45
See Susan Watts, South Korea’s Cloning Controversy, BBC NEWS, July 11, 2006,
http://news.bbc.co.uk/2/hi/programmes/newsnight/4602490.stm (last visited Feb. 17, 2008).
46
Tae-gyu, supra note 16.
47
Id.; Bioethics Act, supra note 6, Additional Provisions.
48
Tae-gyu, supra note 16.
41
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work on stem cells, it did not approve any other scientist’s stem cell research
project under the Bioethics Act until August 2005.49
After the successes in embryonic stem cell research reported by
Professor Hwang and endorsed by the Korean government, the entire world
was shocked to hear that Professor Hwang’s research data had been
fabricated.50 In his 2004 and 2005 papers, Professor Hwang fabricated
results and manipulated photographs to claim that he had cloned the first
human embryo and had derived patient-specific stem cells from cloned
embryos.51 By January 2006, a committee at Seoul National University had
confirmed that the data reported by Professor Hwang in his 2004 and 2005
papers were fabricated.52 Several other reports of ethical violations were
also brought against Professor Hwang,53 and he finally admitted in
November 2005 that two of his research assistants had donated eggs for his
research on embryonic stem cells and he had paid other egg donors for their
donations.54
The knowledge that Professor Hwang’s research was doctored created
an uproar in the scientific community.55 Public faith in embryonic stem cell
research decreased as a result of the scandal.56 The ethical irregularities of
the Hwang scandal can be used as “ammunition [by] activists who are
opposed to the technology on moral grounds.”57 Following the news of the
scandal, the stock prices in the Korean biotech industry fell dramatically, and
the news shook the whole biotech industry.58
49

Korea Okays Stem Cell Research, supra note 35.
Steve Connor, Inquiry Finds Korea’s Human Cloning Was All Fraud, INDEPENDENT (London),
Jan. 11, 2006, at 25.
51
Id.
52
Dennis Normile, Gretchen Vogel & Jennifer Couzin, South Korean Team’s Remaining Human
Stem Cell Claim Demolished, SCIENCE, Jan. 13, 2006, at 156, available at
http://www.sciencemag.org/cgi/reprint/311/5758/156.pdf.
53
See generally Sei Chong, Investigations Document Still More Problems for Stem Cell
Researchers, SCIENCE, Feb. 10, 2006, at 754, available at http://www.sciencemag.org/cgi/reprint/311/
5762/754.pdf (referring to reports stating that Hwang violated ethical principles in his collection of human
oocytes and that the government auditor “could not account for $2.6 million in research funds that Hwang
had received”).
54
Constance Holden, Korean Cloner Admits Lying About Oocyte Donations, SCIENCE, Dec. 2, 2005,
at 1402, available at http://www.sciencemag.org/cgi/reprint/310/5753/1402.pdf.
55
See Lawrence K. Altman & William J. Broad, Global Trend: More Science, More Fraud, N.Y.
TIMES, Dec. 20, 2005, at F5, available at http://www.nytimes.com/2005/12/20/science/20rese.html?
pagewanted=print.
56
Paul Elias & Malcolm Ritter, Science Fraud Shakes Stem Cell Field, LIVESCIENCE, Dec. 24, 2005,
http://www.livescience.com/strangenews/ap_051224_stem_cells.html (last visited Apr. 28, 2008).
57
See David Cyranoski, Korea’s Stem-Cell Stars Dogged by Suspicion of Ethical Breach, 429
NATURE 3 (2004), available at http://www.nature.com/nature/journal/v429/n6987/pdf/429003a.pdf.
58
See Ichiko Fuyuno, Hwang Scandal Hits Korean Biotech Hard, 439 NATURE 265 (2006), available
at http://www.nature.com/nature/journal/v439/n7074/pdf/439265a.pdf.
50
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Korea Recognized the Need to Amend the Bioethics Act in the
Aftermath of the Hwang Scandal

After the Hwang scandal, Korea practically prohibited research on
cloned human embryos.59 Then, in January 2007, NBC began to reconsider
whether to allow research on cloned human embryos.60 NBC recognized
that if it permitted this research, the government would have to revise bills to
qualify more local institutions to get involved in embryonic cloning
research.61 In March 2007, NBC lifted the ban on embryonic stem cell
research on the condition that scientists only use embryos that would
otherwise be discarded instead of creating new embryos for research.62
A few months later, in October 2007, Korea passed an Amendment to
the Executive Ordinance of the Bioethics Act (“Amendment”).63 Among
other procedural changes, the Amendment describes the process to call the
Council of National Bioethics Committee into action and the process to
create new committees for particular areas of bioethics.64 With regard to
embryonic stem cell research, the Amendment lists the parts of an embryo
research plan that require approval before they can be changed.65 These
parts include changes in the purpose of embryological research, the time
span of the research, and the number of embryos used.66 Article 12(2) of the
Amendment limits the permitted sources of eggs used for somatic cell
nucleus transplantation.67 These procedural amendments, however, do not
address the major shortcomings of the Bioethics Act. Primarily, the
amendments do not address the Act’s failure to require voluntary informed
consent to ensure that an egg donor understands her role in the research.
Also, they do not address the Act’s failure to adequately protect human
embryos from undue harm. Another amendment with more extensive
changes to the Bioethics Act has already been submitted to the Korean
National Assembly.68
59

Tae-gyu, supra note 16.
Id.
61
Id.
62
Kim Yoon-mi, Panel Approves Limited Research on Stem Cells, KOREA HERALD, Mar. 24, 2007.
63
Enforcement Ordinance of Bioethics and Biosafety Act, Executive Order No. 20316, partly
amended Oct. 4, 2007, available at http://likms.assembly.go.kr/law/jsp/Law.jsp?WORK_TYPE=
LAW_BON&LAW_ID=B3684&PROM_NO=20316&PROM_DT=20071004& (unofficial translation on
file with author) [hereinafter Enforcement Ordinance].
64
Id. arts. 2, 3.
65
Id. art. 12.
66
Id.
67
Id. art. 12(2).
68
E-mail from Dr. Young-Mo Koo, Assistant Professor, University of Ulsan College of Medicine
Asan Medical Center to author (Dec. 4, 2007, 20:50 PST) (on file with author). Specific information about
60
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THE BIOETHICS ACT DOES NOT ADEQUATELY MEET INTERNATIONAL
STANDARDS FOR PROTECTING EGG DONORS IN EMBRYONIC RESEARCH

Although the Bioethics Act addresses egg donations made by women,
it does not have enough safeguards to protect egg donors from exploitation.
Women may be motivated by altruistic intent to further scientific research
when they donate their eggs.69 However, it is equally plausible, if not more
so, that egg donors are pressured into donating their eggs,70 especially in
Korea where egg donors receive no financial benefit from the donation or
compensation for the trouble of donating their eggs.71 Due to the absence of
monetary incentive to donate, many women may not willingly donate their
eggs, creating a situation where scientists are forced to procure eggs through
unethical or illegal means.72 Recognizing the need to protect these egg
donors, the Bioethics Act requires researchers to obtain written consent from
the donors before using their eggs in research.73 International standards,
however, have more stringent guidelines that govern research on human
subjects, such as the requirement that research participants understand the
aim and scope of the research study, and give their informed and voluntary
consent.74 Korea’s Bioethics Act falls short of the international standards
because it does not have adequate protections for women who donate their
eggs for stem cell research.
A.

International Standards Governing Research on Human Subjects
Apply to Women Egg Donors

The Nuremberg Code and the World Medical Association’s
Declaration of Helsinki are the foremost authorities on human subject
research.75 The International Bioethics Committee (“IBC”), which advises

the changes is very limited, in English as well as in Korean. The Assembly is expected to make a decision
on the amendment later this year. Id.
69
See Human Fertilisation & Embryology Authority, Donor Motivation in the UK,
http://www.hfea.gov.uk/docs/donor_motivation_literature_review.pdf (last visited Feb. 17, 2008).
70
For a discussion of women being forced to donate their eggs, see infra Part III.B.
71
Bioethics Act, supra note 6, art. 13.
72
See infra Part III.B.
73
See Bioethics Act, supra note 6, arts. 5, 9, 15.
74
See infra Part III.B.
75
See Bernard A. Fischer IV, A Summary of Important Documents in the Field of Research Ethics,
32 SCHIZOPHRENIA BULL. 69, 69-70 (2006); see also World Medical Association, Declaration of Helsinki:
Ethical Principles for Medical Research Involving Human Subjects (1964) (amended in 2000 and clarified
in 2002 and 2004), available at http://www.wma.net/e/policy/pdf/17c.pdf [hereinafter Declaration of
Helsinki]; 2 TRIALS OF WAR CRIMINALS BEFORE THE NUREMBERG MILITARY TRIBUNALS UNDER CONTROL
COUNCIL LAW NO. 10 181-82 (U.S. Govt. Printing Office, 1949), reprinted in Office of Human Subjects
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the United Nations Educational, Scientific and Cultural Organization
(“UNESCO”) on ethics in science and technology, has issued a report on the
necessity and quality of consent obtained from research participants.76 The
World Health Organization (“WHO”) incorporated the requirements for
ethical review established in the above-mentioned international guidelines
and issued the Operational Guidelines for Ethics Committees that Review
Biomedical Research.77 Though many of these standards are not binding,
they are aspirational standards, and are widely accepted in the world.78
Most national as well as international regulations treat women who
donate their eggs for scientific research as research subjects. Under the
Declaration of Helsinki, for instance, biomedical research involving human
participants includes research on “identifiable human material and data.”79
Similarly in the United States, under the federal regulations, persons who
provide biological materials for research are research subjects.80 Women
who donate eggs for embryonic stem cell research donate human biological
material, i.e. their eggs, for research. Thus, the women who donate eggs for
stem cell research should be characterized and treated as “research
participants.”81 This classification is important because the Declaration of
Helsinki applies to “human subjects”82 involved in medical research; if
women who donate their eggs for scientific research are considered human
Research, Nuremberg Code, http://ohsr.od.nih.gov/guidelines/nuremberg.html (last visited Apr. 26, 2008)
[hereinafter Nuremberg Code].
76
See U.N. Educ., Sci. and Cultural Org. [UNESCO], International Bioethics Committee, Report of
the International Bioethics Committee of UNESCO (IBC) on Consent, SHS/EST/CIB-13/06/CONF.505/2
Rev 2 (May 19, 2007) [hereinafter UNESCO International Bioethics Committee].
77
World Health Organization [WHO], Operational Guidelines for Ethics Committees that Review
Biomedical Research, at v, TDR/PRD/ETHICS/2000.1 (2000), available at http://www.who.int/tdr/
publications/publications/pdf/ethics.pdf [hereinafter WHO Operational Guidelines].
78
See Bryan Christie, Doctors Revise Declaration of Helsinki, 321 BMJ 913, 913 (2000),
http://www.bmj.com/cgi/reprint/321/7266/913 (last visited Feb. 17, 2008); see International Compilation of
Human Research Protections, Office of Human Research Protections, U.S. Dept. of Health & Human
Services 4 (2008), available at http://www.hhs.gov/ohrp/international/HSPCompilation.pdf. The United
States National Institutes of Health has recognized the Nuremberg Code and the Declaration of Helsinki as
forming the legal foundation for its policies and procedures governing research on human participants.
U.S. Dept. of Health & Human Services, Guidelines for the Conduct of Research Involving Human
Subjects at the National Institutes of Health 15 (Aug. 2004), http://ohsr.od.nih.gov/guidelines/
GrayBooklet82404.pdf (last visited Apr. 26, 2008) [hereinafter Guidelines for the Conduct of Research
Involving Human Subjects]. The Korean Medical Association is a member of the World Medical
Organization. World Medical Association, WMA Medical Ethics Manual, http://www.wma.net/e/
ethicsunit/resources.htm (last visited Feb. 21, 2008).
79
Declaration of Helsinki, supra note 75, ¶ 1.
80
Guidelines for the Conduct of Research Involving Human Subjects, supra note 78, at 4 (citing 45
C.F.R. §46 (1991)).
81
See David Magnus & Mildred K. Cho, Issues in Oocyte Donation for Stem Cell Research,
SCIENCE, June 17, 2005, at 1747, available at http://www.sciencemag.org/cgi/reprint/308/5729/1747.pdf.
82
Declaration of Helsinki, supra note 75, ¶ 1.
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research subjects, then the protections of the Declaration of Helsinki must
apply to them as well.
B.

The Bioethics Act Does Not Have Enough Safeguards to Protect
Women Who Donate Their Eggs for Embryonic Stem Cell Research

With the worldwide acceptance of the Declaration of Helsinki,83
informed consent has become a must-have requirement in the field of
biomedical research.84 As the international guidelines point out, it is equally
important to ensure that the research subjects are participating in research
voluntarily.85 To that end, Korea joined other nations in implementing ways
to protect human research subjects from exploitation, such as by establishing
the IRB review system.86 However, women who donate their eggs for stem
cell research are not adequately protected from possible exploitation because
the Bioethics Act falls short of fulfilling international mandates designed to
ensure voluntary and uncoerced consent. Although the Bioethics Act
contains provisions that lay out the information that should be included in
the consent form, it does not require that egg donors actually understand the
purpose of the research being conducted or appreciate the risks involved.
The IRBs set up by the Bioethics Act have the responsibility of ensuring that
embryonic stem cell research is conducted ethically,87 but the administration
of IRBs under the Bioethics Act makes it difficult for the IRBs to conduct an
independent and unbiased review of the research study.
1.

Because Egg Donors Derive No Personal Benefit from the Research,
Scientists May Unduly Influence Them to Donate Their Eggs

The Bioethics Act expressly prohibits any financial reward in
exchange for egg donations.88 Paying women money in exchange for their
83
See Jeff Blackmer & Henry Haddad, The Declaration of Helsinki: An Update on Paragraph 30,
173 CANADIAN MED. ASS’N J. 1052, 1052 (2005), available at http://www.cmaj.ca/cgi/reprint/173/9/1052;
Tyebkhan G., Declaration of Helsinki: The Ethical Cornerstone of Human Clinical Research, 69 INDIAN J.
DERMATOLOGY VENEREOLOGY LEPROLOGY 245 (2003), available at http://www.ijdvl.com/
text.asp?2003/69/3/245/1013; Christie, supra note 78.
84
Nuremberg Code, supra note 75, ¶ 1; CONTEMPORARY ISSUES IN BIOETHICS 505 (Tom L.
Beauchamp & LeRoy Walters eds., 1978).
85
See Council for International Organizations of Medical Sciences [CIOMS] and the World Health
Organization [WHO], International Ethical Guidelines for Biomedical Research Involving Human Subjects
(2002), http://www.cioms.ch/frame_guidelines_nov_2002.htm (last visited Apr. 26, 2008) [hereinafter
CIOMS Guidelines].
86
See Editorial, Stages of Institutional Review Board Activities, 18 J. KOREAN MED. SCI. 1, 2 (2003),
available at http://jkms.kams.or.kr/2003/pdf/02001.pdf.
87
Bioethics Act, supra note 6, art. 9.
88
Bioethics Act, supra note 6, art. 13.
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eggs may unduly influence them into becoming donors.89 Still, given that
egg donation is an arduous process which exposes donors to several different
types of risks ranging from infertility to cancer,90 some bioethicists argue
that egg donors should be compensated on the basis of time and discomfort
associated with the egg donation process.91 The Bioethics Act, however,
does not even allow women to get reimbursed for their time, pain and
suffering in donating eggs, or for medical treatments for complications
resulting from these procedures.92 Furthermore, at the present time no
successful treatment exists that utilizes embryonic stem cells.93 Even if a
cure for the disease being researched is developed using a woman’s eggs,
she may not be able to afford the treatment, especially if she is from a lower
socio-economic class.94
With no monetary or medical benefit from the donation, it is possible
that many women will have no incentive or motivation to go through the
trouble of donating their eggs. If there are not enough egg donors available,
scientists involved in embryonic stem cell research may have to secretly pay
donors or engage in other “problematic practices” to get the required eggs
for research.95 This has already happened in Korea where investigations
during the Hwang scandal revealed that Professor Hwang had engaged in
unethical practices and had unduly influenced women to obtain their eggs
for research.96

89

Bonnie Steinbock, Payment for Egg Donation and Surrogacy, 7 MOUNT SINAI J. MED. 255, 262

(2004).
90
Sarah B. Angel, The Value of the Human Egg: An Analysis of Risk and Reward in Stem Cell
Research, 22 BERKELEY J. GENDER L. & JUST. 183, 203 (2007).
91
Robert Steinbrook, Egg Donation and Human Embryonic Stem-Cell Research, 354 NEW ENG. J.
MED. 324, 326 (2006), available at http://content.nejm.org/cgi/reprint/354/4/324.pdf.
92
See Bioethics Act, supra note 6.
93
Wolfgang Lillge, The Case for Adult Stem Cell Research, 21ST CENTURY SCIENCE AND
TECHNOLOGY
MAGAZINE,
2001-2002,
http://www.21stcenturysciencetech.com/articles/winter01/
stem_cell.html (last visited Feb. 17, 2008).
94
See Anne McLaren, Insight Commentary, Ethical and Social Considerations of Stem Cell
Research, 414 NATURE 129, 131 (2001), available at http://www.nature.com/nature/journal/
v414/n6859/pdf/414129a0.pdf; see also Thomas A. Shannon, Ethical Issues in Stem Cell Therapy From the
Micro to the Macro, WPI TRANSFORMATIONS (2003), http://www.wpi.edu/News/Transformations/
2003Spring/stemcell.html (“the product of such research will also be costly because investors will be
seeking an adequate return on their investment”); see generally Greg Nelson, Man Travels to Russia for
Stem Cell Treatment, MORNING SUN, Jan. 27, 2008, http://www.themorningsun.com/stories/
012708/loc_russia.shtml (last visited Feb. 17, 2008) (narrating a man’s trip to Russia to obtain adult stem
cell treatment which cost him “more than $25,000” for the first trip and $10,000 for the second).
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Steinbrook, supra note 91, at 326.
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ONLINE,
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Professor Hwang had paid women money in exchange for their eggs.97
Between November 2002 and December 2005, Professor Hwang’s
laboratory had monetarily compensated more than ninety-seven women for
their egg donations.98 The Bioethics Act expressly prohibits any “financial
reward” in exchange for eggs.99 Any payments for egg donations made after
January 2005 violated the Bioethics Act.100 Professor Hwang had also
obtained eggs from junior scientists in his laboratory, which, according to
some commentators, constituted coercion.101 As one critic points out, “in the
strict hierarchy of a scientific laboratory in a Confucian society like South
Korea, junior members often feel great pressure to please their superiors.”102
In fact, one researcher from Professor Hwang’s laboratory who had donated
her eggs later wrote in an email, “I shouldn't have done it this way, not
giving up [my position in the research team] until the end, not fighting
against the professor.”103 In light of the Hwang scandal and the very real
possibility that Korean women may feel pressured or coerced into donating
their eggs, it is important that egg donors are adequately protected from
exploitation.
2.

The Bioethics Act Does Not Require that Egg Donations Be Made
Voluntarily and Free of Coercion

Before allowing research on human subjects, international standards
require that research participants give voluntary and informed consent to
participate in the research.104 Informed consent and voluntary consent are

97
Aera Han, The Ethical and Regulatory Problem in the Stem Cell Scandal, 21-22 (2006)
(unpublished LL.M dissertation, Harvard University), http://leda.law.harvard.edu/leda/data/769/Han06.rtf
(last visited May 10, 2008).
98
Id. at 25.
99
Bioethics Act, supra note 6, art. 13.
100
It is true that some of the payments made by Professor Hwang’s research took place before the
Bioethics Act came into effect in 2005. Yet, the purchasing of eggs, even if not illegal under the Bioethics
Act, still violated other guidelines applicable to Professor Hwang’s research. For instance, the Korean
Medical Association’s Guidelines on Research of Cloning Lives, issued in 1999, prohibit trading of eggs.
Han, supra note 97, at 21-22.
101
See Holden, supra note 54, at 1402; Jin Hyun-joo, Ethical Issues Surface Over Cell Research:
Junior Researcher Says She Was Forced to Donate Eggs, KOREA HERALD, Jan. 3, 2006; Gary Younge,
Embryo Scientist Quits Team Over Ethics Fear, GUARDIAN (London), Nov. 14, 2005.
102
James Brooke, Korean Leaves Cloning Center in Ethics Furor, N.Y. TIMES, Nov. 25, 2005, at A1,
available at http://www.nytimes.com/2005/11/25/international/asia/25clone.html?_r=1&oref=slogin.
103
Han, supra note 97, n. 89 (citing Hwang Woo Suk Gyosu-Ui Yunlimunje-E Daehan
Jungganbogoseo [The Intermediary Report on the Ethical Problems of Dr. Woo Suk Hwang’s Research]).
104
See Nuremberg Code, supra note 75, ¶ 1; Declaration of Helsinki, supra note 75, ¶ 20; UNESCO
International Bioethics Committee, supra note 76, art. 5.
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two distinct requirements.105 Informed consent deals with the physician or
researcher’s duty to provide adequate information to the patient or research
subject. Voluntariness of consent deals with the patient’s decision-making
ability to give free consent to participate.106 Recognizing this difference,
international guidelines require informed as well as voluntary consent from
human subjects involved in the research. For instance, the Nuremberg Code
requires that, along with being fully informed of the extent of their
involvement in research, human research participants should be in a position
to “exercise free power of choice” to participate.107 Similarly, the
Declaration of Helsinki requires physicians to pay special attention to
vulnerable research participants who might be “subject to giving consent
under duress” or “who will not benefit personally from the research.”108
The Bioethics Act does not require that the consent obtained from
research participants be voluntary. Unlike the Guidelines for Korean Good
Clinical Practice which require physicians to pay special attention to trials
involving vulnerable subjects—those who may be unduly influenced by
expectation of benefits, or those who may be afraid to refuse consent due to
a retaliatory response from a senior member109—Article 5 of the Bioethics
Act only guarantees a research participant the right to “consent, or refuse
consent” to participate in the research after being “fully informed” of his or
her involvement.110 It is true that the Bioethics Act allows egg donors to
withdraw their consent,111 but withdrawal of consent is only meaningful if
the Bioethics Act requires voluntary consent in the first place.
Because the Bioethics Act does not require women to voluntarily
consent to egg donations, it does not protect women from the various
sources of duress that may force them to donate their eggs. By expressly
prohibiting any sort of monetary compensation for egg donations, the
Bioethics Act tries to ensure that women are not swayed to donate their eggs
because of money. As commentators have pointed out, however, payment
for eggs is only one of many ways women donors can be unduly influenced
into donating their eggs.112 Societal and familial pressures and the
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BRAIN & LANGUAGE 110, 110 (2000).
106
Id.
107
Nuremberg Code, supra note 75, ¶ 1.
108
Declaration of Helsinki, supra note 75, ¶ 8.
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authoritative presence of someone in a hierarchy are other causes of duress
and coercion that may make a woman’s consent to donate involuntary.113
The Bioethics Act, however, is quiet on these other possible sources of
duress. For example, it is not clear whether egg donations made by junior
researchers in Professor Hwang’s laboratory would have constituted
coercion under the Bioethics Act,114 even though the donations undoubtedly
violated the Declaration of Helsinki115 which states that “special attention is
also required for those who cannot give or refuse consent for themselves, for
those who may be subject to giving consent under duress.”116 The Bioethics
Act’s silence on the issue of voluntary consent highlights its failure to
protect vulnerable subjects who might not be in a situation to deny consent
to stem cell research participation.117 By addressing only monetary
compensation as a potential form of duress and by not expressly requiring
that a woman voluntarily consent to donate her eggs, the Bioethics Act falls
short of the international guidelines and fails to adequately protect the
autonomy of egg donors.
3.

The Bioethics Act Violates International Standards by Not Requiring
that Egg Donors Understand the Research and Associated Risks

The International Bioethics Committee states that “it is necessary [in
scientific research] to make the [research subject] aware of the aim of the
research, the methodology and the duration, expected benefits for him/her or
for other persons concerned and the risks involved.”118 As a member state of
UNESCO,119 Korea is expected to follow the guidelines set forth by the
International Bioethics Committee.
The Korean Bioethics Act does not require researchers to inform the
research subjects of the potential risks involved in the research study. The
Bioethics Act only mandates that the written consent form state the purpose
of producing an embryo, details regarding the storage and disposal of
113
Russell Korobkin, Buying and Selling Human Tissues for Stem Cell Research, 49 ARIZ. L. REV.
45, 53 (2007).
114
See generally Bioethics Act, supra note 6 (denying financial reward for donating oocytes, but not
protecting an egg donor from other possible sources of coercion or undue influence).
115
See Han, supra note 97, at 23; Hwang Admits In-House Egg Donations, KOREA TIMES, Nov. 25,
2005.
116
Declaration of Helsinki, supra note 75, ¶ 8.
117
The Guidelines for Korean Good Clinical Practice do not apply to protect the women who donate
their eggs for embryonic stem cell research because the Guidelines are not laws and the Bioethics Act states
that only “other laws concerning bioethics” may be relied upon. Bioethics Act, supra note 6, art. 3.
118
UNESCO International Committee of Bioethics, supra note 76, ¶ 13.
119
UNESCO, Member States, http://erc.unesco.org/cp/MSList_alpha.asp?lg=E (last visited Feb. 20,
2008).
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embryos, whether remaining embryos can be used for purposes other than
pregnancy, information about the procedures for withdrawal of consent, and
other information regarding consenters' rights or any other information the
MHW finds necessary.120 The Act’s inherent vagueness as to what
constitutes “other necessary information”121 is compounded by the Act’s
failure to require scientists to disclose information about “expected benefits”
of the research and the “risks involved” as required by UNESCO
guidelines.122
After a full disclosure of expected benefits and potential risks of a
particular research study, the international standards place a further burden
on researchers and physicians. The Declaration of Helsinki requires that
research subjects understand the information presented to them by the
physician.123 Thus, scientists can only utilize a subject in a research study
after a full disclosure of expected benefits and risks involved and after
making sure that the subject understands the information presented to him or
her. The Korean Bioethics Act does not require that research subjects
understand the information presented to them before allowing them to
participate in stem cell research.
“Embryo producing medical institutions,” facilities that “collect
sperms or oocytes in order to produce an embryo,” are required under the
Bioethics Act to “explain in detail the contents of [the consent form to the
oocyte donors] before obtaining a written consent.”124 Requiring a signed,
written consent from oocyte donors is an important first step in ensuring that
research subjects are not exploited. However, as one commentator points
out, compliance with research ethics should move away from “checking off
boxes” and towards a “culture of conscience.”125 The use of “readability
tests” and other measures to ensure that the consent form uses simple words
and sentences such that a woman with little formal education can understand
it is one way of creating that culture of conscience.126 Instead of the
researcher providing large amounts of complicated information to egg
donors, it might be helpful to have a counselor present at the meetings who
120
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uses visual aids to explain the contents of the consent form.127 Egg donors
may feel more comfortable asking the counselor questions regarding the
research and stating their unwillingness to participate. Moreover, the
counselor likely has more experience than a scientist in communicating
information. The Bioethics Act lacks “conscience” because it takes no steps
to ensure that only women who truly understand the manifold risks of
donating their eggs are allowed to donate eggs.
The text of the Bioethics Act also warrants the requirement of
comprehension of the information presented to research participants.
Allowing scientists to conduct research when a research subject fails to
understand the “aims, [and] methods” of the study contradicts the purpose of
the Bioethics Act.128 The Bioethics Act aims to “protect human dignity and
to prevent harm to human beings.”129 How can the Bioethics Act prevent
harm to human beings if it does not require that the human subjects who
volunteer to participate in a research study actually understand the potential
risks and harms arising from the research? For instance, a woman may
decide to go to an embryo producing medical institution to donate her eggs
to embryonic stem cell research thinking that the procedure will not be any
different from donating blood. To prevent unnecessary harm to egg donors,
it is important that the woman understand all the risks associated with
donating eggs, risks that include Ovarian Hyperstimulation Syndrome,
future infertility, and cancer.130 It is only after a woman understands and
appreciates the risks involved in donating eggs and the purpose of the
research study that she can give a truly informed and voluntary consent.
The dangers present when a research subject does not understand the
purpose of the research are heightened in embryonic stem cell research.
Women who donate eggs entirely for research purposes are not seeking any
personal medical or reproductive benefit from the donation, but are taking
risks for the potential benefit to others and may be mistaken about the use of
the resulting embryo.131 Therapeutic misconception has been pointed out as
a real and significant danger of embryonic stem cell research.132 A
127
Daniel W. Fitzgerald, Cécile Marotte, Rose Irene Verdier, Warren D. Johnson & Jean William
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description of the potential uses of stem cells along with reasons why stem
cell research is so promising can make it confusing for the donor to
understand that there are no “embryonic stem-cell based therapies currently
available.”133 Egg donors must understand the nature of embryonic stem cell
research so they can make an informed decision about whether they want to
become research subjects. The Bioethics Act “aims to prevent harm to
human beings,”134 which includes preventing harm to egg donors. Requiring
that egg donors actually understand the research, its goals, and inherent risks
in donating their eggs is an internationally accepted way of preventing this
type of harm.
4.

The Bioethics Act Fails to Heed WHO’s Guidelines that Require IRBs
to Function Independently of the Research Institution

International organizations have recognized the importance of having
ethics committees that review research that is conducted on human subjects.
The Declaration of Helsinki requires that the protocol of research involving
human subjects “should be submitted for consideration, comment, guidance,
and where appropriate, approval to a[n] [independent] specially appointed
ethical review committee.”135 It further states that the researcher should
submit and the committee should review “information regarding funding,
sponsors, institutional affiliations, other potential conflicts of interest and
incentives for subjects.”136 WHO has also published the Operational
Guidelines for Ethics Committees That Review Biomedical Research.137
These guidelines establish “an international standard for ensuring quality in
ethical review” of biomedical research.138
Recognizing the international importance of having ethics committees
review biomedical research, Korea enacted the Korean Good Clinical
Practice (“KGCP”) in 1995.139 In January 2001, the Korean government
revised the KGCP based on the International Conference on Harmonization
of Good Clinical Practice, an international ethics guideline for clinical
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trials.140 This revision required that legal and institutional bases be
established to ensure that the constitution and operation of IRBs are
standardized and upgraded to international levels.141 In March 2002, IRB
members in major hospitals, biomedical researchers, medical directors of
pharmaceutical companies and officers from health authorities founded the
Korean Association of Institutional Review Boards (“KAIRB”) under the
auspices of the Korean Academy of Medical Sciences.142 The main mission
of the KAIRB is to help Korean IRBs build up ethical review capacity to the
international level.143
Against this backdrop, the Korean Bioethics Act stipulates that every
embryo research institution set up its own IRB.144 The law describes the
organization and administration of IRBs145 and lays out their role in
reviewing biomedical research. However, the Bioethics Act falls short of
international standards, particularly the WHO Operational Guidelines,
because it does not require that the IRB act independently of the research
institution.
International standards guiding the organization and functioning of
ethics committees are much more stringent than the Korean Bioethics Act.
WHO Operational Guidelines require a member of the ethics committee to
“withdraw from the meeting for the decision procedure concerning an
application where there arises a conflict of interest.”146 “Conflict of interest”
exists when a board member has “financial, material, institutional, or social
ties to the research” or there are other factors present that may “jeopardize
his/her (their) ability to provide a free and independent evaluation of the
research focused on the protection of the research participants.”147
Compared to the WHO Guidelines, the Bioethics Act takes a narrower
approach to determine when an IRB member may be ineligible to participate
in the review process. Article 10 of the Bioethics Act states that each IRB
will be made up of five to nine people, and will include one person who is
“not engaged in the fields of life science or medical science, as well as one
person [who is] external to the institution.”148 Members who are “involved
in research, development, or utilization of life sciences and biotechnologies”
140
141
142
143
144
145
146
147
148
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that are being reviewed by the Board are barred from participating in the
review process.149
The Bioethics Act does not define what it means by the phrase
“involved in research, development, or utilization” of biotechnology.
Webster’s Dictionary defines the verb “involve” as “to engage as a
participant.”150 So the Bioethics Act bars participants of embryological stem
cell research from being on the committee that reviews the research. Even
though “involved” can cover a broad range of relationships that might be
problematic to a fair assessment of biomedical research, the use of the
phrase “in research, development, or utilization of life sciences and
biotechnologies” restricts its reach. Only members who have a scientific,
institutional or financial interest in the research or utilization of a
biotechnology can be said to be “involved” so as to bar them from
participating in the review process. Members who are not “involved” in the
research, development, or utilization of the technology, but have other
“social ties”151 with the research or development of the biotechnology would
not be barred under the Bioethics Act from being on the IRB that reviews the
research protocol.152 The international guidelines, however, explicitly
prohibit an ethics committee member from having any “social ties” or any
other relationship that might jeopardize their decision-making ability from
being on the review board.153 For example, some of the members of the IRB
that reviewed Professor Hwang’s research were alleged to have been
originally nominated by Professor Hwang’s team.154 Under the international
guidelines, this social relationship between Professor Hwang and the IRB
members he nominated would prevent those members from reviewing his
research. However, under the Bioethics Act, the members were allowed to
review Professor Hwang’s research because they were not “involved” in the
study. International standards ensure that a research proposal or protocol
will face an independent review process, whereas there is no such guarantee
under the Bioethics Act in Korea.
149
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THE KOREAN BIOETHICS ACT FAILS TO SUGGEST AN APPROPRIATE
TIMEFRAME TO USE HUMAN EMBRYOS IN SCIENTIFIC RESEARCH

Embryonic stem cell research raises important questions about the use
of human embryos in scientific research.155 On the one hand, embryonic
stem cell research has the potential to cure diseases such as Alzheimer’s and
Parkinson’s and treat conditions like spinal cord injury, heart disease, and
diabetes.156 On the other hand, the process of deriving stem cells from an
embryo results in the embryo’s destruction.157 Ethics committees around the
world, including in Korea, are struggling to determine the moral and legal
status of human embryos that are used in stem cell research.158 If an embryo
is a potential human being, should it be granted all the protections that a
human being enjoys? Any country that allows stem cell research to be
conducted on human embryos should answer this question and justify the
improvement in human health that results from the destruction of potential
human beings. Unfortunately, the Korean Bioethics Act fails to do just that
due to its inability to adequately protect human embryos from unnecessary
destruction.
A.

International Guidelines Require Special Attention Be Paid to the Use
of Human Embryos in Scientific Research

International guidelines carefully regulate the use of human embryos
in scientific research. Research involving human subjects includes “research
on identifiable human material” under the Declaration of Helsinki.159 This
provision applies to identifiable human tissue, which includes human
embryos.160 This interpretation is consistent with the intent of the World
Medical Association (“WMA”) to extend the Declaration of Helsinki to
human embryos as indicated in WMA Statement on In-Vitro Fertilization
and Embryo Transplantation, which states that the Declaration of Helsinki
will apply to “all clinical research in respect to . . . embryo
155
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transplantation.”161 Thus a human embryo is considered a “human subject”
under the Declaration of Helsinki, making it eligible for a “careful
assessment of predictable risks and burdens in comparison with foreseeable
benefits” to the embryo before allowing research.162 In fact, the WMA’s
Statement on Assisted Reproductive Technologies expressly states that
“research [on human embryos] should be carefully controlled and should be
limited to areas in which the use of alternative materials will not provide an
adequate alternative.”163 It also emphasizes the need to handle and
manipulate human embryos in a manner that would “protect [them] from
abuse.”164
Many countries have closely traced the language of the Declaration of
Helsinki and the WMA statements in laws that regulate research on human
embryos. For instance, in Australia, before the Human Research Ethics
Committee approves any proposal that involves research on human embryos,
it must be satisfied that “the likely benefits of the proposed research cannot
be achieved without using human embryos,” and the potential benefit of the
proposed research is enough and justifiable to allow harm to human
embryos.165 Similarly, the Singapore Bioethics Advisory Committee
recognizes that “a human embryo has a special status as a potential human
being” which is distinct from a living human being.166 Like Australia,
Singapore also utilizes a balancing of respect to the embryo with the benefits
arising from proposed research.167 The greater the promised medical benefit
of the proposed research, the more likely that the Singapore Bioethics
Committee would permit embryonic research.
The need to protect human embryos used in scientific experiments has
been interpreted as a focus on the importance of the research goals and the
way embryos are handled in research, instead of whether embryos may be
161
World Medical Association, Statement on In-Vitro Fertilization and Embryo Transplantation
(adopted by the 39th World Medical Assembly, Madrid, Spain, Oct. 1987), available at
http://www.wma.net/e/policy/e5.htm [hereinafter Statement on In-Vitro Fertilization and Embryo
Transplantation]. The World Medial Association Statement on In-Vitro Fertilization and Embryo
Transplantation was rescinded at the General Assembly in South Africa in 2006, but this fact does not
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destroyed.168 Thus, for example, the Warnock Report in the United
Kingdom prohibits “frivolous or unnecessary” use of human embryos in
scientific research.169 The international guidelines prohibiting misuse of
human beings for research purposes are applied to human embryos in the
United States as well.170
B.

The Bioethics Act Lacks the Language Necessary to Ensure
Appropriate Use of Human Embryos in Stem Cell Research

The Bioethics Act does contain some restrictions on the use of human
embryos in stem cell research, but these limitations are not adequate. The
Bioethics Act prohibits reproductive cloning,171 while allowing therapeutic
cloning of embryos.172 Furthermore, any research on human embryos has to
be performed before “the embryological primitive streaks appear in their
developmental process.”173 In contrast to research on other human cells and
tissues, any research involving human embryos must occur for one of the
three enumerated purposes.174 The research must be aimed at 1) developing
“contraception and infertility treatments,” 2) “curing rare or incurable
diseases,” or 3) any other research approved by the President.175
Researchers are also required to follow specific guidelines regarding the
storage, usage, and disposal of embryos.176
The above-mentioned safeguards put in place by the Bioethics Act to
ensure proper use of human embryos in scientific research fall short of
international standards. International standards require that stringent
conditions be met before human embryos can be used in scientific
research.177 Yet the Korean Bioethics Act has no provisions that provide
guidance as to when it would be appropriate to use embryos in stem cell
research. Nowhere in the Bioethics Act does it require that, where possible,
168
Young-Rhan Um, Special Section, South Korea: Human Embryo Research, 12 CAMBRIDGE Q.
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169
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statement.htm#text28 (last visited Apr. 28, 2008).
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researchers should use alternatives to human embryos as required by the
WMA Statement on Assisted Reproductive Technologies.178 The Bioethics
Act allows NBC and the President to approve any research on human
embryos.179 The Bioethics Act fails to give effect to the Helsinki
Declaration because it contains no provision requiring NBC or the President
to weigh the risks of embryonic research against foreseeable benefits before
approving the research under Article 17 of the Bioethics Act.180 The
Bioethics Act’s silence on what constitutes appropriate use of human
embryos for research contradicts the explicit requirements of the
international standards.
V.

KOREA SHOULD AMEND THE BIOETHICS ACT TO MAKE IT COMPATIBLE
WITH INTERNATIONAL STANDARDS

Advances in biotechnology must be balanced against the legal and
ethical risks to research subjects. The Bioethics Act should include
mechanisms to ensure the adequacy and quality of informed consent
received from egg donors, to review the circumstances under which
informed consent is obtained, and to determine the ability of IRBs to
effectively perform their role. It should also include provisions promoting
alternatives to the use and destruction of human embryos. As Korea is
considering amending its Bioethics Act, it can incorporate the aspects of
international protections that would work in Korea to protect research
subjects while advancing scientific research and development.
In August 2005, the Director of the Bioethics Policy Division of the
MHW issued a statement claiming that South Korea has “concrete and
comprehensive regulations on the scope of embryo research.”181 The
Director pointed to the Bioethics Act to demonstrate that human embryo
production and research is strictly regulated and written consent is required
from sperm and oocyte donors.182 The position of the Korean government
changed in 2006, after the Hwang scandal became public knowledge. Since
then, several different governmental organizations and entities have
expressly stated the need for the government to “step up its efforts to assure
proper ethical research standards” and “establish a scrupulous system for
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donating human eggs for research purposes.”183 To that end, Korea should
amend the Bioethics Act to ensure that higher ethical standards of scientific
research are upheld in embryonic stem cell research.
A.

The Bioethics Act Should Require IRBs to Ensure that the Informed
Consent Obtained from Egg Donors Is Voluntary

Korea should incorporate adequate and effective ways to monitor the
circumstances under which women are giving consent to donate eggs. One
such way could be for the Korean Act to explicitly require researchers to
obtain voluntary consent that is not obtained by coercion, undue influence or
duress. The IRB should have the responsibility to make sure that women are
not coerced into donating eggs due to their dependent status, monetary
inducements, or their “compromised ability to offer fully voluntary
consent.”184 IRB members could interview women donors to determine their
motives in donating eggs and the circumstances in which they agree to
donate.185 An independent counselor not involved in the research project
could also counsel egg donors on the various aspects of egg donation.186
Other amendments could include placing a maximum limit on the
number of times a woman can donate eggs for research187 and prohibiting
women working in the lab from donating their eggs.188 Furthermore, the
Bioethics Act should require that women donors actually understand the
research in which they are participating and truly appreciate the risks
involved in donating eggs. The IRB should review the “adequacy,
completeness, and understandability of written and oral information”189 that
is given to egg donors. Inclusion of a requirement that women undertand all
the information that is presented to them is the first step in the right
183
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direction—upholding and protecting their dignity. Where human research
subjects are involved, the highest degree of ethics must be applied.
B.

The Bioethics Act Should Include Provisions Assuring the Proper Use
of Human Embryos in Stem Cell Research

Korea should follow Australia and Singapore’s approach to regulating
embryonic stem cell research to ensure that human embryos are not
unnecessarily harmed.190 The Bioethics Act should require MHW to weigh
the potential benefits of a proposed research against the harm done to the
embryos before approving any research on stem cells that are derived from
human embryos. Following Singapore’s approach, the Korean Bioethics Act
could also require scientists to draw embryonic stem cells from existing stem
cell lines before destroying more embryos to get stem cells.191
The Bioethics Act should also seek to promote technology that does
not destroy human embryos. The Act already allows research on adult stem
cells.192 Adult stem cells are found in the tissues of a grown human being.193
Derivation of adult stem cells does not harm the person from whom those
cells are derived; neither does it harm an embryo.194 Thus, instead of merely
giving the national and regional governments an option of supporting
research on adult stem cells, the Korean government should actively support
research on adult stem cells. This is even more important in light of the fact
that the benefits of embryonic stem cells are speculative, but adult stem cells
have already been successfully used in numerous patients to allow them to
regrow damaged tissues.195
Finally, the Korean Bioethics Act should include provisions that
provide an incentive for scientists to engage in researching new
biotechnologies. In late 2007, scientists were able to transform human skin
cells into stem cells.196 Then, in January of 2008, an Australian scientist was
able to extract a single cell from an embryo, a technique which did not
negatively affect the future development of the embryo.197 Korea should
190
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invest money in and actively promote these approaches and the development
of additional alternatives to destroying embryos to get stem cells.
VI.

CONCLUSION

In recent years, Korea has continued to invest money and resources in
embryonic stem cell research. Embryonic stem cell research poses unique
challenges because egg donors and human embryos are harmed during a
research study from which they do not receive any direct benefit. As it
currently stands, the Bioethics Act is inadequate to protect women who
donate their eggs for stem cell research because the Act does not require that
women consent to the donation voluntarily and free of any undue influence.
The Bioethics Act also does not require that the egg donors understand the
research in which they are participating and its associated risks. Moreover,
the Bioethics Act falls short of international standards because it does not
limit the use of human embryos in scientific research.
To strengthen its protections of women and embryos, Korea’s
Bioethics Act should look to international standards and incorporate
requirements that would protect women and embryos from being exploited.
The Bioethics Act should require that egg donors understand the purpose of
the research study and its associated risks before giving their voluntary
consent. In addition, the Act should promote research that does not require
the destruction of human embryos to obtain stem cells. Bringing the
Bioethics Act into greater conformity with international standards will assure
that Korea takes an ethical approach to embryonic stem cell research and
will make it possible for Korea to fulfill the stated aims of the Bioethics Act
while staying ahead in stem cell research.

